IL-1β secreted by macrophage M2 promotes metastasis of osteosarcoma via NF-κB/miR-181α-5p/RASSF1A/Wnt pathway

Zhi-Peng Han1, Dong-Biao Liu1, Liu-Qing Wu1

  • 1Department of Orthopedics, The Third Xiangya Hospital of Central South University, Changsha 410013, China.

Abstract

Insights

Interleukin-1β (IL-1β) from M2 tumor-associated macrophages promotes osteosarcoma (OS) metastasis. Targeting the NF-κB/miR-181α-5p/RASSF1A/Wnt pathway with RASSF1A or miR-181α-5p can suppress OS spread.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Ras-associated domain family protein1 isoform A (RASSF1A) is often absent in osteosarcoma (OS) and can suppress metastasis.
  • Tumor-associated macrophages (M2-TAMs) may mediate RASSF1A's effect on OS metastasis.
  • The role of IL-1β secreted by M2-TAMs in relation to RASSF1A in OS metastasis is unclear.

Purpose of the Study:

  • To investigate the relationship between IL-1β secreted by M2-TAMs and RASSF1A in osteosarcoma (OS) metastasis.
  • To elucidate the underlying molecular mechanisms involving miR-181α-5p, NF-κB, and the Wnt pathway.

Main Methods:

  • Flow cytometry to quantify M2-TAM markers (CD68, CD204).
  • RT-qPCR to measure IL-1β, Arg-1, and miR-181α-5p levels.
  • MTT, scratch wound healing, and Transwell assays to assess OS cell proliferation, migration, and invasion.
  • Western blot to evaluate RASSF1A, GSK-3β, p-GSK-3β, β-catenin, MMP-2, and MMP-9.
  • Dual-luciferase reporter and RNA immunoprecipitation (RIP) assays to confirm direct binding of miR-181α-5p and RASSF1A.

Main Results:

  • M2-TAMs exhibited elevated CD68, CD204, Arg-1, and IL-1β levels.
  • Overexpression of RASSF1A and knockdown of miR-181α-5p suppressed OS cell invasion and migration via the Wnt pathway.
  • IL-1β from M2-TAMs promoted OS metastasis through the RASSF1A/Wnt pathway, modulated by miR-181α-5p and NF-κB.

Conclusions:

  • IL-1β secreted by M2-TAMs drives OS metastasis.
  • Suppression of OS metastasis can be achieved by inhibiting miR-181α-5p or overexpressing RASSF1A.
  • The NF-κB/miR-181α-5p/RASSF1A/Wnt pathway is a key mechanism in OS metastasis and a potential therapeutic target.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.2K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.8K